PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26512452-10	2016	Mechanistic studies revealed that celecoxib-induced cardiac protection against CH and cardiac dysfunction was due to inhibition of apoptosis via the murine double mimute 2/P53 pathway, inhibition of inflammation via the AKT/mTOR/NF-kappaB pathway and inhibition of oxidative stress via increases in nuclear factor E2-related factor-2-mediated gene expression of multiple antioxidants.	Celecoxib	34-43	transformation related protein 53, pseudogene	Mus musculus	172-175	
19174577-0	2009	Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.	Celecoxib	124-133	transformation related protein 53, pseudogene	Mus musculus	31-34	
17201140-7	2006	CONCLUSION: Celecoxib may be useful as an adjuvant therapy for breast cancer containing p53 mutations due to its ability to both induce p53-independent mitochondria-mediated apoptosis and exert anti-angiogenic potential.	Celecoxib	12-21	transformation related protein 53, pseudogene	Mus musculus	88-91	
17201140-7	2006	CONCLUSION: Celecoxib may be useful as an adjuvant therapy for breast cancer containing p53 mutations due to its ability to both induce p53-independent mitochondria-mediated apoptosis and exert anti-angiogenic potential.	Celecoxib	12-21	transformation related protein 53, pseudogene	Mus musculus	136-139	
16052515-6	2006	TUNEL staining of the tumor tissues showed a marked increase in the apoptosis in the combination group as compared to the celecoxib- or docetaxel-treated groups and this was associated with an increase in the intratumor p53 expression.	Celecoxib	122-131	transformation related protein 53, pseudogene	Mus musculus	220-223	
14743207-0	2004	Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib.	Celecoxib	147-156	transformation related protein 53, pseudogene	Mus musculus	81-84	
26723251-6	2016	Celecoxib attenuated the severity of liver steatohepatitis and reduced the number of apoptotic cells, accompanied by increasing the activity of Akt and decreasing expression of p53.	Celecoxib	0-9	transformation related protein 53, pseudogene	Mus musculus	177-180